Couples and Microbial Diversity
- Sponsor
- Tampere University Hospital
- Study ID
- NCT07315568
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Infections
- Infertility
- Transmission
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
Couples and Microbial Diversity (CLARITY) - study is a prospective study that investigates the risks and dynamics of different microbes and transmission among couples to optimize the prevention and control strategies as well as improvement for infertility treatments. The study will be conducted at the Infertility Clinic of Tampere University Hospital, Tampere Finland; and will recruit 200 couples undergoing infertility investigations and treatments. Oral and genital tract samples will be collected at baseline and every six months during a two-year follow-up period. Background information will be obtained through a secure online questionnaire. Couples who achieve pregnancy will be followed according to the CLARITY protocol until delivery, after which families will transition to the CLARITY-Baby extension study. Samples from both the newborn and parents will be collected at delivery and again at six months postpartum, accompanied by an online follow-up questionnaire completed by the parents.
Key Dates
- First listed
- Jan 2, 2026
- Start date
- Jan 5, 2026
- Status verified
- Dec 2025
- Primary completion
- Jun 30, 2027
- Completion
- Dec 30, 2031
Study Design
- Enrollment
- 200 participants (estimated)
Arms
- Arm: CLARITYCouples attending the Tampere University Hospital (TAUH) infertility clinic due to problems in conceiving during the past 12 months.
Primary Outcome Measure
Risks and dynamics of different microbes and transmission among infertile couples [ Time Frame: From enrolment to 24 month follow-up samples ]
Central Contacts
- Karolina Louvanto, Professor+358504713838
- Marianne Kamaja, MD
Related Studies
- Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES)Recruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Bethesda, Maryland
- Study to Create Potential Cell-Based Therapies to Treat Human Disease and DisabilityEnrolling By Invitation · Stanford University · Stanford, California
- A Phase I Study of Mozobil in the Treatment of Patients With WHIMSPHASE1/PHASE2 · Recruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Bethesda, Maryland
- Discarded Materials StudyRecruiting · Reproductive Medicine Associates of New Jersey · Basking Ridge, New Jersey